BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Decline in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 4,100 shares, a decline of 10.9% from the January 15th total of 4,600 shares. Based on an average daily volume of 2,700 shares, the short-interest ratio is currently 1.5 days.

BioNxt Solutions Trading Up 4.3 %

Shares of OTCMKTS:BNXTF traded up $0.01 on Friday, hitting $0.33. The company had a trading volume of 9,561 shares, compared to its average volume of 3,001. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.49. The stock has a market cap of $37.86 million, a price-to-earnings ratio of -8.35 and a beta of 0.69. The stock has a 50 day moving average price of $0.27 and a 200 day moving average price of $0.21.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings data on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.